Raymond Cohen

Raymond Cohen

Direttore/Membro del Consiglio presso RXSIGHT, INC.

Patrimonio netto: 2 M $ in data 31/07/2026

67 anni
Health Technology
Commercial Services
Finance

Profilo

Mr. Raymond W.
Cohen is an Independent Director at RxSight, Inc., an Independent Director at Kestra Medical Technologies Ltd., a Partner at Zhuhai Sherpa Equity Investment Management Co. Ltd., a Chairman at Archimedes Vascular, Inc., a Chairman at BioBeat Technologies Ltd., a Chairman at BiVACOR, Inc., a Chairman at Nalu Medical, Inc., an Independent Director at ECS Opco 1 LLC, a Member at Forum for Corporate Directors and a Venture Advisor at Andera Partners SCA. He is on the Board of Directors at RxSight, Inc., Tulavi Therapeutics, Inc., Kestra Medical Technologies Ltd., BioGenex Laboratories, Inc. and ECS Opco 1 LLC.
Mr. Cohen was previously employed as an Independent Director by InspireMD, Inc., a Chairman by SoniVie Ltd., a Chairman by BioVentrix, Inc., a Chief Executive Officer & Director by Axonics, Inc., an Independent Non-Executive Director by Spectrum Pharmaceuticals, Inc., a Chairman by Lombard Medical, Inc., a Non-Executive Chairman by JenaValve Technology GmbH, a Chief Executive Officer by Boston Scientific Corp., a Chief Executive Officer & Director by Vessix Vascular, Inc., an Independent Director by CardioGenesis Corp., a Chairman by BioLife Solutions, Inc., a Non-Executive Chairman by Syncroness, Inc., a Chairman, President & Chief Executive Officer by Cardiac Science, Inc., a President by Diagnostic Monitoring, a Chairman by DYSIS Medical Ltd., a Chairman by JenaValve Technology, Inc., a Non-Executive Chairman by Lombard Medical Technologies Ltd., a Chairman by LoneStar Heart, Inc., a Member-Biomedical Leadership Council by OCTANe, and a Chief Executive Officer & Director by The Irvine Co. LLC.
He also served on the board at Kestra Medical Technologies, Inc., LifeWatch AG, CardioPolymers, Inc., Cardiac Science Corp., BioTelemetry, Inc. and Nyxoah SA. He received his undergraduate degree from State University of New York at Binghamton.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
0,09%
17/07/2026 50.903 ( 0,09% ) 1 M $ 31/07/2026
17/06/2026 66.532 ( 0,16% ) 399 857 $ 31/07/2026
10/04/2026 92.417 ( 0,2% ) 60 071 $ 31/07/2026

Posizioni attive di Raymond Cohen

SocietàPosizioneInizio
RXSIGHT, INC. Direttore/Membro del Consiglio 31/07/2025
Consulente / Consigliere -
Investitore di Private Equity 01/01/2025
Presidente -
Presidente -
Direttore/Membro del Consiglio 01/06/2025
Direttore/Membro del Consiglio 01/11/2013

Precedenti posizioni note di Raymond Cohen

SocietàPosizioneFine
INSPIREMD, INC. Direttore/Membro del Consiglio 01/07/2026
Direttore/Membro del Consiglio 01/01/2025
░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Raymond Cohen

Formazione di Raymond Cohen

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

65

Relazioni di 1° grado

36

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private36

Health Technology

Health Technology

Commercial Services

Health Technology

Finance

Health Technology

Health Technology

Electronic Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Consumer Services

Health Technology

Industrial Services

Health Technology

Health Technology

Forum for Corporate Directors

Diagnostic Monitoring

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

  1. Mercati
  2. Insiders
  3. Raymond Cohen